David Happel

David Happel

President and Chief Executive OfficeratSagimet Biosciences· In proxies 2022–2025

Pay in FY2025+258% from the year before · Sagimet Biosciences stock +31.6% the same year

David Happel was paid $3.2M in FY2025 (Dec), up 258%. Sagimet Biosciences stock rose 31.6% that year.

Pay$100 in the stock at the end of FY23 → $109
Pay is from the Summary Compensation Table of each Sagimet Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sagimet BiosciencesPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role -33%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?